Norton Rose Fulbright advised Beijing Capital Grand on the deal. Beijing Capital Grand Limited (BCG, 1329.HK) completed its privatisation by way of a scheme of arrangement...
Beijing Capital City Development Group’s Privatisation Of Beijing Capital Grand Limited
L’Occitane International SA’s €6 Billion Privatization
Norton Rose Fulbright acted for L’Occitane Group S.A. on the deal. L’Occitane International, the cosmetics group behind renowned brands such as L’Occitane en Provence, Sol de...
Shandong Boan Biotechnology Co., Ltd.’s Listing on the Hong Kong Stock Exchange
Allen & Overy advised Shandong Boan Biotechnology Co., Ltd. on the deal. The transaction involed the spin-off from Luye Pharma Group (2186.HK) and a separate listing of...
China Mengniu Dairy’s Pre-Conditional Privatisation of Yashili International
Norton Rose Fulbright advised HSBC on the deal, while Zhong Lun advised Yashili International Holdings. HSBC in its capacity as financial adviser to China Mengniu Dairy...
Dongyue Group Limited’s HK$3.335 Billion Shares Placing
Norton Rose Fulbright has advised Dongyue Group Limited on the deal. Dongyue Group is a Chinese leading chemical engineering company, primarily engaged in developing and producing...
Beijing Capital Group Co., Ltd.’s US$681 Million Privatisation Of Beijing Capital Land Ltd.
Slaughter and May advised China International Capital Corporation Hong Kong Securities Limited on the deal. Norton Rose Fulbright advised Beijing Capital Land Ltd. Clifford Chance advised...